Recce Limited announced that in support of company's focus on its activities on the East Coast of Australia, the company has successfully established a small but important Head Office at L34, 50 Bridge Street Sydney. The company has leased property in Macquarie (Technology) Park ­ Australia's pharmaceutical hub ­ in order to develop a pilot-plant facility for the manufacture of RECCE® 327 for anticipated future human trials.

The company's establishment of premises on the East Coast of Australia has seen Mr. James Graham, Executive Director and responsible for corporate and marketing developments take up duties permanently at the CBD address ­ the location of company's future board meetings, with Eastern States based newly-appointed Non-Executive Directors Ms. Bernadette Murdoch (Marketing Expert and PharmCo Executive) and Dr. Dominic Barnes (Medical Practitioner and Pharmaceutical Expert).